• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Gamma-Glutamyl Transpeptidase to Neutrophil Ratio: Prognostic Indicator for Hepatocellular Carcinoma Patients Post-Curative Resection [Letter].γ-谷氨酰转肽酶与中性粒细胞比值：肝细胞癌患者根治性切除术后的预后指标[信函]
J Hepatocell Carcinoma. 2024 Dec 3;11:2391-2392. doi: 10.2147/JHC.S508062. eCollection 2024.
2
Gamma-Glutamyl Transpeptidase to Neutrophil Ratio: Prognostic Indicator for Hepatocellular Carcinoma Patients Post-Curative Resection [Response to Letter].γ-谷氨酰转肽酶与中性粒细胞比值：肝细胞癌患者根治性切除术后的预后指标[对信件的回复]
J Hepatocell Carcinoma. 2024 Dec 19;11:2481-2482. doi: 10.2147/JHC.S509528. eCollection 2024.
3
Gamma-Glutamyl Transpeptidase to Neutrophil Ratio as Prognostic Indicator for Hepatocellular Carcinoma Patients Post-Curative Resection.γ-谷氨酰转肽酶与中性粒细胞比值作为肝细胞癌患者根治性切除术后的预后指标
J Hepatocell Carcinoma. 2024 Oct 27;11:2077-2085. doi: 10.2147/JHC.S478186. eCollection 2024.
4
Value of GPR, APPRI and FIB-4 in the early diagnosis of hepatocellular carcinoma: a prospective cohort study.GPR、APPRI 和 FIB-4 在肝细胞癌早期诊断中的价值：一项前瞻性队列研究。
Jpn J Clin Oncol. 2024 Feb 7;54(2):129-136. doi: 10.1093/jjco/hyad147.
5
A new model based on gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts prognostic outcome after curative resection of solitary hepatocellular carcinoma.基于γ-谷氨酰转肽酶与血小板比值（GPR）的新模型预测单发肝细胞癌根治性切除术后的预后结局。
Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101509. doi: 10.1016/j.clinre.2020.07.014. Epub 2021 Mar 19.
6
Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.碱性磷酸酶、γ-谷氨酰转肽酶和乳酸脱氢酶对肝癌患者行肝切除术后的预后价值。
Int J Surg. 2016 Dec;36(Pt A):143-151. doi: 10.1016/j.ijsu.2016.10.033. Epub 2016 Oct 25.
7
Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma.γ-谷氨酰转肽酶与碱性磷酸酶比值、γ-谷氨酰转肽酶与天冬氨酸氨基转移酶比值和丙氨酸氨基转移酶与天冬氨酸氨基转移酶比值联合对甲胎蛋白阴性肝细胞癌的诊断价值。
Cancer Med. 2021 Jul;10(14):4844-4854. doi: 10.1002/cam4.4057. Epub 2021 Jun 18.
8
A novel prognostic index-neutrophil times γ-glutamyl transpeptidase to lymphocyte ratio (NγLR) predicts outcome for patients with hepatocellular carcinoma.一种新型预后指数——中性粒细胞与γ-谷氨酰转肽酶比值与淋巴细胞比值（NγLR）可预测肝细胞癌患者的预后。
Sci Rep. 2017 Aug 23;7(1):9229. doi: 10.1038/s41598-017-09696-y.
9
Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection.接受根治性切除的肝细胞癌患者术前炎症标志物的预后价值
Cancer Cell Int. 2021 Sep 17;21(1):500. doi: 10.1186/s12935-021-02204-3.
10
Gamma-glutamyl transpeptidase-platelet ratio, systemic immune inflammation index, and system inflammation response index in invasive Aspergillosis.γ-谷氨酰转肽酶/血小板比值、全身免疫炎症指数和侵袭性曲霉菌病的系统炎症反应指数。
Rev Assoc Med Bras (1992). 2021 Jul;67(7):1021-1025. doi: 10.1590/1806-9282.20210475.

引用本文的文献

1
Gamma-Glutamyl Transpeptidase to Neutrophil Ratio: Prognostic Indicator for Hepatocellular Carcinoma Patients Post-Curative Resection [Response to Letter].γ-谷氨酰转肽酶与中性粒细胞比值：肝细胞癌患者根治性切除术后的预后指标[对信件的回复]
J Hepatocell Carcinoma. 2024 Dec 19;11:2481-2482. doi: 10.2147/JHC.S509528. eCollection 2024.

本文引用的文献

1
Gamma-Glutamyl Transpeptidase to Neutrophil Ratio as Prognostic Indicator for Hepatocellular Carcinoma Patients Post-Curative Resection.γ-谷氨酰转肽酶与中性粒细胞比值作为肝细胞癌患者根治性切除术后的预后指标
J Hepatocell Carcinoma. 2024 Oct 27;11:2077-2085. doi: 10.2147/JHC.S478186. eCollection 2024.
2
Liver Cancer Etiology: Old Issues and New Perspectives.肝癌病因学：旧问题与新视角。
Curr Oncol Rep. 2024 Nov;26(11):1452-1468. doi: 10.1007/s11912-024-01605-7. Epub 2024 Oct 10.
3
Body mass index is a risk factor for postoperative morbidity after laparoscopic hepatectomy of hepatocellular carcinoma: a multicenter retrospective study.体质指数是腹腔镜肝癌切除术术后发病率的一个风险因素：一项多中心回顾性研究。
J Cancer Res Clin Oncol. 2024 Oct 5;150(10):445. doi: 10.1007/s00432-024-05979-w.
4
Alcohol consumption and hepatocellular carcinoma: novel insights from a prospective cohort study and nonlinear Mendelian randomization analysis.饮酒与肝细胞癌：一项前瞻性队列研究和非线性孟德尔随机化分析的新见解。
BMC Med. 2022 Oct 28;20(1):413. doi: 10.1186/s12916-022-02622-8.
5
Hepatocellular carcinoma.肝细胞癌
Lancet. 2022 Oct 15;400(10360):1345-1362. doi: 10.1016/S0140-6736(22)01200-4. Epub 2022 Sep 6.
6
Prediction models for cardiovascular disease risk in the general population: systematic review.普通人群心血管疾病风险预测模型：系统评价
BMJ. 2016 May 16;353:i2416. doi: 10.1136/bmj.i2416.

Gamma-Glutamyl Transpeptidase to Neutrophil Ratio: Prognostic Indicator for Hepatocellular Carcinoma Patients Post-Curative Resection [Letter].

作者信息

Hao Yu

机构信息

School of Graduate, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150006, People's Republic of China.

出版信息

J Hepatocell Carcinoma. 2024 Dec 3;11:2391-2392. doi: 10.2147/JHC.S508062. eCollection 2024.

DOI:10.2147/JHC.S508062
PMID:39649244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11624679/
Abstract
摘要